352 related articles for article (PubMed ID: 23240738)
1. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of pneumonia among patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
[TBL] [Abstract][Full Text] [Related]
3. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
4. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.
Gupta G; Lautenbach E; Lewis JD
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240
[TBL] [Abstract][Full Text] [Related]
6. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.
Chang K; Lee HS; Kim YJ; Kim SO; Kim SH; Lee SH; Song EM; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1928-1936.e2. PubMed ID: 29857150
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies.
Ning L; Liu R; Li S; Shan G; Du H; Zhang J; Chen W; Zhang F; Yu J; Xu G
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):219-227. PubMed ID: 31650411
[TBL] [Abstract][Full Text] [Related]
8. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX
Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099
[TBL] [Abstract][Full Text] [Related]
9. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
Long MD; Herfarth HH; Pipkin CA; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):268-74. PubMed ID: 20005977
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Santella C; Bitton A; Filliter C; Bessissow T; Vutcovici M; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2022 Feb; 28(2):176-182. PubMed ID: 33999136
[TBL] [Abstract][Full Text] [Related]
11. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
Côté-Daigneault J; Bessissow T; Nicolae MV; Nie R; Bitton A; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2019 Apr; 25(5):914-918. PubMed ID: 30295818
[TBL] [Abstract][Full Text] [Related]
12. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
Khan N; Shah Y; Trivedi C; Lewis JD
Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA.
Singer D; Thompson-Leduc P; Gupta D; Cheng WY; Poston S; Ma S; Pawlowski JE; Duh MS; Morris ED; Devine F; Farraye FA
Gastroenterol Rep (Oxf); 2023; 11():goad016. PubMed ID: 37064550
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
Chupin A; Perduca V; Meyer A; Bellanger C; Carbonnel F; Dong C
Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
Khan N; Trivedi C; Kavani H; Lewis J; Yang YX
Inflamm Bowel Dis; 2019 Jan; 25(2):345-351. PubMed ID: 29982646
[TBL] [Abstract][Full Text] [Related]
16. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
[TBL] [Abstract][Full Text] [Related]
17. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS
Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222
[TBL] [Abstract][Full Text] [Related]
18. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
[TBL] [Abstract][Full Text] [Related]
19. Incidence of herpes zoster in patients with inflammatory bowel disease.
Calm A; Calafat M; González-Muñoza C; Cañete F; Roig C; Mañosa M; García-Planella E; Domènech E
Gastroenterol Hepatol; 2024; 47(6):598-604. PubMed ID: 38316174
[TBL] [Abstract][Full Text] [Related]
20. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD
JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
